Spiros Servos

Commercial Strategy Consultant

Spiros is a biopharmaceutical business expert and deal-maker with over 20 years experience in the biotech industry.  He has extensive understanding of both scientific principles with business strategy and has a track record in commercialising biopharmaceuticals that include gene therapy, vaccines and RNA therapeutics assets.  Spiros has helped secure over $110M in upfront payments through 30+ partnerships, totaling over $7B in value. Through combining scientific expertise with business acumen, he is able to consistently deliver exceptional results.  Spiros has held key positions at Oxford Gene Technology, Emergent BioSolutions & Oxford BioMedica.  He holds a PhD in molecular biology and a MBA from Imperial College, London. 

Experience includes:

- Partnering

- Disposition of Assets

- Due Diligence

- Scouting for New Technologies

- Alliance Management

- Business Intelligence

- Valuations (Risk adjusted NPVs)

- Commercialisation Evaluation

Spiros Servos
Back To Top
contactus@greyrigge.com